序号 |
标题 |
次数 |
作者 |
发布时间 |
66871 |
白蛋白结合肽修饰的地塞米松脂质体,ABD-Lip/Dex,定制服务 |
76 |
axc |
2024-12-20 |
66872 |
Maleimido-mono-amide-DOTA cas:1006711-90-5 |
68 |
zyl |
2024-12-20 |
66873 |
2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate,ADC定制 |
76 |
kx |
2024-12-20 |
66874 |
Tos-PEG3-CH2COOtBu |
82 |
h |
2024-12-20 |
66875 |
溶菌酶修饰的百里香精油脂质体,定制服务 |
134 |
axc |
2024-12-20 |
66876 |
HO-PEG7-CH2COOH |
116 |
h |
2024-12-20 |
66877 |
Mc-vc-PABC-SP 141 -ADC连接子 |
103 |
zyl |
2024-12-20 |
66878 |
CAS: 2055024-53-6,Boc-PEG6-Val-Cit-PAB-OH |
122 |
WYQ |
2024-12-20 |
66879 |
cas:1252257-56-9,2,5-dioxopyrrolidin-1-yl 3-oxo-1-(pyridin-2-yldisulfanyl)-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oate |
69 |
kx |
2024-12-20 |
66880 |
Amino-PEG12-CH2COOH |
60 |
h |
2024-12-20 |
66881 |
CAS: 2055024-54-7,Boc-PEG4-Val-Cit-PAB-OH,叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
64 |
WYQ |
2024-12-20 |
66882 |
HO-PEG12-CH2COOH |
70 |
h |
2024-12-20 |
66883 |
cas:663599-07-3,1-(4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
69 |
kx |
2024-12-20 |
66884 |
E-选择素结合肽修饰并加载四嗪的膜融合脂质体,EBP-Tz-FLs,定制服务 |
93 |
axc |
2024-12-20 |
66885 |
Amino-PEG3-CH2COOH |
73 |
h |
2024-12-20 |
66886 |
CAS: 2055024-55-8,Boc-PEG2-Val-Cit-PAB-OH |
116 |
WYQ |
2024-12-20 |
66887 |
Tos-PEG4-CH2COOH |
79 |
h |
2024-12-20 |
66888 |
cas:663598-85-4,N-succinimidyl 4-(5-nitro-pyridin-2-yldithio)-pentanoate, ADC试剂 |
67 |
kx |
2024-12-20 |
66889 |
负载姜黄素的胆碱修饰的脂质体,NP1/Cur,定制服务 |
77 |
axc |
2024-12-20 |
66890 |
Boc-NH-PEG4-CH2COOH |
61 |
h |
2024-12-20 |
66891 |
CAS: 1951424-92-2,Fmoc-Ala-Ala-Asn(Trt)-OH |
82 |
WYQ |
2024-12-20 |
66892 |
CAS:1618096-56-2 Mc-Dexamethasone 抗体-药物偶联物(ADC) |
102 |
zyl |
2024-12-20 |
66893 |
CAS: 1639939-40-4,MC-Val-Ala-PAB-PNP |
122 |
WYQ |
2024-12-20 |
66894 |
Fmoc-NH-PEG4-CH2COOH |
54 |
h |
2024-12-20 |
66895 |
perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate,ADC定制 |
67 |
kx |
2024-12-20 |
66896 |
CAS: 1870916-87-2,MC-Val-Ala-PAB,6-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-N-((S)-1-(((S)-1-((4-(羟甲基)苯基)氨基)-1-氧代丙烷-2-基)氨基)-3-甲基-1-氧代丁-2-基)己酰胺 |
63 |
WYQ |
2024-12-20 |
66897 |
Amino-PEG4-CH2COOH |
92 |
h |
2024-12-20 |
66898 |
CAS号1473403-87-0 MC-SN38 抗体-药物偶联物(ADC) |
113 |
zyl |
2024-12-20 |
66899 |
Alkyne-Val-Cit-PAB-PNP(CAS号:2748039-77-0) |
65 |
WYQ |
2024-12-20 |
66900 |
Fmoc-NH-PEG4-CH2CH2COOH |
106 |
h |
2024-12-20 |
66901 |
cas:1007215-94-2,tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oate |
67 |
kx |
2024-12-20 |
66902 |
HS-PEG5-CH2CH2NH2 hydrochloride |
96 |
h |
2024-12-20 |
66903 |
Thiol-PEG5-amine |
55 |
h |
2024-12-20 |
66904 |
SGD-1910 (Mc-Val-Ala-PBD ) cas:1342820-51-2 |
76 |
zyl |
2024-12-20 |
66905 |
Alkyne-Val-Cit-PAB-FAM(CAS号:2748039-76-9 |
96 |
WYQ |
2024-12-20 |
66906 |
cas:60444-78-2,2,5-Dioxopyrrolidin-1-yl 4-formylbenzoate, 4-甲酰苯甲酸N-琥珀酰亚胺酯,抗体药物偶联物(ADC) |
72 |
kx |
2024-12-20 |
66907 |
HO-PEG8-CH2CH2COOH |
101 |
h |
2024-12-20 |
66908 |
Fmoc-Val-Ala-PAB-PNP(CAS号:1394238-92-6) |
77 |
WYQ |
2024-12-20 |
66909 |
Thiol-PEG7-propionic acid |
96 |
h |
2024-12-20 |
66910 |
Boc-NH-PEG11-CH2CH2N3 |
75 |
h |
2024-12-20 |
66911 |
cas:478801-48-8,5-azidopentanoic acid N-hydroxysuccinimide ester, ADC试剂 |
102 |
kx |
2024-12-20 |
66912 |
MC-Val-Cit-PAB-OH CAS编号:159857-80-4 |
113 |
WYQ |
2024-12-20 |
66913 |
MA-PEG4-vc-PAB-DMEA-duocarmycin SA一种用于开发抗体-药物偶联物的 DNA 修饰剂 |
123 |
zyl |
2024-12-20 |
66914 |
CAS: 175724-30-8,Amino-Tri-(t-butoxycarbonylethoxymethyl)-methane |
93 |
WYQ |
2024-12-20 |
66915 |
Boc-NH-PEG10-CH2CH2NH2 |
76 |
h |
2024-12-20 |